Skip to main content
Log in

CRP and acute renal rejection: a marker to the point

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objectives

C-reactive protein (CRP) is increased in end-stage renal disease patients. Recent studies have shown positive associations between inflammatory markers and cardiovascular mortality in kidney transplant recipients. The aim of the present study was to examine the correlation between CRP and early detection of renal allograft rejection. Furthermore, investigate the association between pretransplant levels of CRP with the development of acute renal allograft rejection as a possible predictive marker.

Methods

Ninety-one renal transplant recipients were sequentially analyzed. The median follow up of patients was 8 weeks. Basal and 8 weeks post transplant CRP levels were assessed.

Results

CRP levels were significantly higher in allograft rejection both in the pretransplant (n = 25, P = 0.001) and postransplant (= 33, = 0.001) phases when compared to those without rejection. By stepwise multiple regression analysis, rejection in transplanted patients was independently correlated to albumin/creatinine ratio and CRP 8 weeks after transplantation.

Conclusion

Elevated pretransplant serum CRP level is a risk predictor for acute rejection episodes and may be a useful predictive marker in the follow-up of post-transplantation patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. www.USRDS.com

  2. Desvaux D, Schwarzinger M, Pastural M, Baron C, Abtahi M, Berrehar F, Lim A, Lang P, le Gouvello S (2004) Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance. Transplantation 78(5):647–653

    Article  PubMed  CAS  Google Scholar 

  3. Fink JC, Onuigbo MA, Blahut SA, Christenson RH, Mann D, Bartlett ST, Weir MR (2002) Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis 39(5):1096–1101

    Article  PubMed  CAS  Google Scholar 

  4. Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey DJ, Sinnott PJ, Raftery MJ, Yaqoob MM (2004) Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am J Kidney Dis 43(3):502–507

    Article  PubMed  CAS  Google Scholar 

  5. Perez RV, Brown DJ, Katznelson SA, Dubin JA, Müller HG, Chang T, Rudich SM, McVicar JP, Kaysen GA (2000) Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation 69(5):869–874

    Article  PubMed  CAS  Google Scholar 

  6. Jabs WJ, Meier M, Lamprecht P, Steinhoff, Nitschk M (2011) Local expression of C-reactive protein is associated with deteriorating graft function in acute and chronic failure of kidney transplants. Nephron Clin Pract 117(4):c390–c397

    Article  PubMed  CAS  Google Scholar 

  7. Krüger B, Walberer A, Debler J, Böger CA, Farkas S, Reinhold SW, Obed A, Schlitt HJ, Fischereder M, Banas B, Krämer BK (2010) Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes? Atherosclerosis 210(2):637–642

    Article  PubMed  Google Scholar 

  8. Sancho A, Pastor MC, Bayés B, Sánchez A, Morales-Indiano C, Doladé M, Romero R, Lauzurica R (2010) Posttransplant inflammation associated with onset of chronic kidney disease. Transplant Proc 42(8):2896–2898

    Article  PubMed  CAS  Google Scholar 

  9. Martínez-Dolz L, Almenar L, Reganon E, Vila V, Sánchez-Soriano R, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A (2009) What is the best biomarker for diagnosis of rejection in heart transplantation? Clin Transplant 23(5):672–680

    Article  PubMed  Google Scholar 

  10. Böger CA, Götz A, Stubanus M, Banas B, Deinzer M, Krüger B, Holmer SR, Schmitz G, Riegger GA, Krämer BK (2005) C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease. Kidney Int 68(1):217–227

    Article  PubMed  Google Scholar 

  11. Grootendorst DC, de Jager DJ, Brandenburg VM, Boeschoten EW, Krediet RT, Dekker FW (2007) Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients-no additional power for mortality. Prediction with high-sensitivity CRP. Nephrol Dial Transplant 22(11):3277–3284

    Article  PubMed  CAS  Google Scholar 

  12. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE, Hingorani AD (2003) Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heartdisease. Arterioscler Thromb Vasc Biol 23(11):2063–2069

    Article  PubMed  CAS  Google Scholar 

  13. Prasad K (2006) C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 24(1):33–50

    Article  PubMed  CAS  Google Scholar 

  14. Srivastava M, Eidelma O, Torosyan Y, Jozwik C, Mannon RB, Pollard HB (2011) Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection. Proteomics Clin Appl 5:311–321

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amal M. El-shehaby.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roshdy, A., El-Khatib, M.M., Rizk, M.N. et al. CRP and acute renal rejection: a marker to the point. Int Urol Nephrol 44, 1251–1255 (2012). https://doi.org/10.1007/s11255-011-0098-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-0098-4

Keywords

Navigation